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Background
The known functions of ceruloplasmin oxidase activity
(COA) include copper transportation, iron metabolism,
antioxidant defense and involvement in angiogenesis and
coagulation. The role of ceruloplasmin oxidase involving
the interaction of oxidant and anti-oxidant balance in aller-
gic diseases is still unknown. It was previously reported that
synthesis of ceruloplasmin was situmulated by interleukin-
1 in normal and copper-deficient rat models concluding
that ceruloplasmin is dependent for oxidase activity. More-
over, the copper ions had been suggested as an explanation
for the sensitivity of asthmatic individuals by their biologic
effects of inhaled particulate air pollution. In vivo experi-
ments on finding the cytokines involved in acute-phase
protein response showed that there are three major cyto-
kines; interleukin 1-beta, 6 and TNF-alpha. Our study was
designed to examine the changes in COAs in severe persis-
tent asthma-allergic rhinitis, new diagnosed allergic
asthma-allergic rhinitis and allergic rhinitis patients.
Methods
The study included 20 age- and sex-matched healthy
individuals as control group (group I); group II was
including 15 newly diagnosed allergic asthma - allergic
rhinitis; group III was including 15 patients with severe
persistent asthma - allergic rhinitis and in the fourth
group there were 20 patients with allergic rhinitis. Group
III was divided in two groups, severe persistent asthma-
allergic rhinitis who were pre- (III-A) and post-treated
(III-B) with omalizumab. Group IV was divided to two
groups, pre- (IV-A) and post-treatment (IV-B) with
specific subcutaneous immunotherapy modalities. All the
post-treatment measurements were 12 months after the
therapy. All the patients were assessed by the skin prick
test, high sensitive C-reactive protein (hs-CRP) and COA.
Results
hs-CRP and COA levels were measured in all groups.
There were significant differences between group I and
groups III-A, III-B, IV-A and IV-B; group II and groups
III-A, III-B, IV-A and IV-B; group III-A and groups III-B,
IV-A and IV-B; group III-A and groups IV-A and IV-B;
and group IV-A and IV-B. Interestingly, there was a corre-
lation between the hs-CRP and COA levels in Group III-A.
Conclusions
Our data suggest that hs-CRP and COA levels might be
an indicator of an inflammation and important in reve-
lation of patients with allergy related diseases, especially
of asthma patients.
Author details
1Internal Medicine, Allergy and Immunology, Education and Research
Hospital, Turkey. 2Akdeniz University, Turkey. 3Cancer Institute, Sweden.
4Antalya Education and Research Hospital, Turkey. 5Department of Internal
Medicine, Antalya Education and Research Hospital, Antalya, Turkey. 6Division
of Cellular & Molecular Biology, Toronto Hospital, University Health Network,
Toronto, ON, Canada.
Published: 23 April 2013
doi:10.1186/1939-4551-6-S1-P64
Cite this article as: Yalcin et al.: Mechanisims of asthma and allergic
disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and
allergic rhinitis. World Allergy Organization Journal 2013 6(Suppl 1):P64.1Internal Medicine, Allergy and Immunology, Education and Research
Hospital, Turkey
Full list of author information is available at the end of the article
Yalcin et al. World Allergy Organization Journal 2013, 6(Suppl 1):P64
http://www.waojournal.org/content/6/S1/P64
© 2013 Yalcin et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
